Literature DB >> 12500002

A critical assessment of items on the Pediatric Crohn's Disease Activity Index.

H J Loonen1, A M Griffiths, M P Merkus, H H F Derkx.   

Abstract

OBJECTIVES: Questions have been raised about the discriminative value of the three laboratory items (hematocrit, erythrocyte sedimentation rate, and albumin) and three physical items (height, perirectal disease, and extraintestinal manifestations) included in the Pediatric Crohn's Disease Activity Index (PCDAI). The aim of this study was to analyze the value of these six "criticized" items to the discriminative properties of the PCDAI.
METHODS: Data from 71 children with Crohn's disease visiting an outpatient clinic were analyzed. Physician global assessment of disease activity was used as the gold standard. A "basic index" was calculated by subtracting the score of the six criticized items from the score of the PCDAI calculated in the standard fashion. Multivariate logistic regression procedures identified which items significantly contributed to the "basic index". Receiver operating characteristic curves were produced comparing the standard PCDAI score to the "basic index" and a new "clinical index" which included only the criticized items truly contributing to the discriminatory ability of the "basic index".
RESULTS: Logistic regression models identified only perirectal disease as contributing to the discriminative abilities of the basic index. The clinical index therefore consists of the three history items (abdominal pain, number of liquid stools, and general well-being), three physical examination items (weight loss, abdominal examination, and perirectal disease) and no laboratory tests. The clinical index had an area under the curve not significantly inferior to that of the original PCDAI (0.93 [95% confidence interval, 0.89-0.99] vs. 0.96 [95% confidence interval, 0.92-0.99]).
CONCLUSIONS: A clinical index consisting of three history items and three physical examination items has an accuracy equal to the standard PCDAI in distinguishing children with disease in remission from those with a relapse.

Entities:  

Mesh:

Year:  2003        PMID: 12500002     DOI: 10.1097/00005176-200301000-00017

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  17 in total

1.  Coping strategies and quality of life of adolescents with inflammatory bowel disease.

Authors:  H J van der Zaag-Loonen; M A Grootenhuis; B F Last; H H F Derkx
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

2.  Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease.

Authors:  Eva Szigethy; Simona I Bujoreanu; Ada O Youk; John Weisz; David Benhayon; Diane Fairclough; Peter Ducharme; Joseph Gonzalez-Heydrich; David Keljo; Arvind Srinath; Athos Bousvaros; Margaret Kirshner; Melissa Newara; David Kupfer; David R DeMaso
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-05-10       Impact factor: 8.829

3.  Stability of Emotional and Behavioral Functioning in Youth with Inflammatory Bowel Disease.

Authors:  Bonney Reed-Knight; Debra Lobato; Sarah Hagin; Elizabeth L McQuaid; Ronald Seifer; Sheryl J Kopel; Julie Boergers; Jack H Nassau; Kristina Suorsa; Barbara Bancroft; Neal S LeLeiko
Journal:  Child Health Care       Date:  2013-10-22

4.  Short pediatric Crohn's disease activity index for quality improvement and observational research.

Authors:  Michael D Kappelman; Wallace V Crandall; Richard B Colletti; Anthony Goudie; Ian H Leibowitz; Lynn Duffy; David E Milov; Sandra C Kim; Bess T Schoen; Ashish S Patel; John Grunow; Evette Larry; Gerry Fairbrother; Peter Margolis
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

Review 5.  Ultrasonographic imaging of inflammatory bowel disease in pediatric patients.

Authors:  Liliana Chiorean; Dagmar Schreiber-Dietrich; Barbara Braden; Xin-Wu Cui; Reiner Buchhorn; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

6.  C-Reactive Protein/Albumin Ratio at Diagnosis of Pediatric Inflammatory Bowel Disease: A Retrospective Multi-Center Study.

Authors:  Aleksandra Glapa-Nowak; Mariusz Szczepanik; Aleksandra Banaszkiewicz; Jarosław Kwiecień; Anna Szaflarska-Popławska; Urszula Grzybowska-Chlebowczyk; Marcin Osiecki; Jarosław Kierkuś; Marcin Dziekiewicz; Jarosław Walkowiak
Journal:  Med Sci Monit       Date:  2022-09-14

7.  Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study.

Authors:  Mohamed Attauabi; Gorm Roager Madsen; Flemming Bendtsen; Anne Vibeke Wewer; Rune Wilkens; Johan Ilvemark; Nora Vladimirova; Annette Bøjer Jensen; Frank Krieger Jensen; Sanja Bay Hansen; Hartwig Roman Siebner; Yousef Jesper Wirenfeldt Nielsen; Jakob M Møller; Henrik S Thomsen; Simon Francis Thomsen; Helene Andrea Sinclair Ingels; Klaus Theede; Trine Boysen; Jacob T Bjerrum; Christian Jakobsen; Maria Dorn-Rasmussen; Sabine Jansson; Yiqiu Yao; Ewa Anna Burian; Frederik Trier Møller; Viktoria Fana; Charlotte Wiell; Lene Terslev; Mikkel Østergaard; Kristina Bertl; Andreas Stavropoulos; Jakob B Seidelin; Johan Burisch
Journal:  BMJ Open       Date:  2022-06-27       Impact factor: 3.006

8.  Rates and predictors of oral medication adherence in pediatric patients with IBD.

Authors:  Neal S LeLeiko; Debra Lobato; Sarah Hagin; Elizabeth McQuaid; Ronald Seifer; Sheryl J Kopel; Julie Boergers; Jack Nassau; Kristina Suorsa; Jason Shapiro; Barbara Bancroft
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

9.  Depressive symptoms in youth with inflammatory bowel disease compared with a community sample.

Authors:  Bonney Reed-Knight; Debra Lobato; Sarah Hagin; Elizabeth L McQuaid; Ronald Seifer; Sheryl J Kopel; Julie Boergers; Jack H Nassau; Kristina Suorsa; Barbara Bancroft; Jason Shapiro; Neal S Leleiko
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

10.  Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease.

Authors:  Denise L Jacobson; Athos Bousvaros; Lori Ashworth; Rebecca Carey; Lydia A Shrier; Sandra K Burchett; Harmony Renna; Ying Lu
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.